PDF) L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
Russia faces shortage of drugs against Parkinson's disease
MODOPAR et génériques : mise au point sur les ruptures de stock et les tensions d'approvisionnement
BIJSLUITER - Teva Pharma Belgium
Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa® – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
Summary of Product Characteristics
Prospect Levodopa Benserazide - Parkinson
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
FOGLIO ILLUSTRATIVO: INFORMAZIONI PER L'UTILIZZATORE Levodopa/Benserazide Teva Italia 200 mg/50 mg Compresse Medicinale equivale
Frontiers | The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats | npj Parkinson's Disease
Леводопа/Бенсеразид-Тева — инструкция по применению, дозы, побочные действия, отзывы о препарате Леводопа/Бенсеразид-Тева: таблетки, 200 мг+50 мг — Энциклопедия лекарств РЛС
Levodopa / benserazide-Teva": treoracha úsáide, analogs agus athbhreithnithe
Levodopa | Teva UK
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/ benserazide treated Parkinson's disease patients with wearing-off | SpringerLink
Levodopa | Teva UK
PDF) Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease | Juan Burguera and Juan Gómez-esteban - Academia.edu
Brain Sciences | Free Full-Text | Advanced Parkinson’s Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis
PDF) Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: A case series
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study | SpringerLink